Cary Street Partners’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
159,788
+2,196
+1% +$158K 0.31% 75
2026
Q1
$9.96M Buy
157,592
+1,364
+0.9% +$96K 0.25% 94
2025
Q4
$10.6M Buy
156,228
+950
+0.6% +$63.5K 0.26% 87
2025
Q3
$9.61M Buy
155,278
+2,262
+1% +$124K 0.25% 97
2025
Q2
$7.56M Buy
153,016
+4,164
+3% +$170K 0.21% 115
2025
Q1
$4.88M Buy
148,852
+1,228
+0.8% +$41.9K 0.15% 151
2024
Q4
$5.13M Buy
+147,624
New +$5.17M 0.17% 134

Other funds holding APH

Cary Street Partners's APH Position: Q2 2026 in Review

Cary Street Partners increased its Amphenol (APH) stake by 1.4% in Q2 2026, buying an estimated $158K and bringing the position to 159,788 shares worth $14.1M. The position accounts for 0.31% of the portfolio, ranked #75.

Cary Street Partners first reported a position in APH in Q4 2024 and has held it in 7 quarters since. 2,340 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Cary Street Partners held 159,788 shares of Amphenol worth $14.1M as of Q2 2026.
  • Cary Street Partners bought 2,196 Amphenol shares in Q2 2026, an estimated $158K.
  • Amphenol made up 0.31% of Cary Street Partners's portfolio in Q2 2026, its #75 holding.
  • Cary Street Partners first reported a position in Amphenol in Q4 2024 and has held it in 7 quarters since.
  • 2,340 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.